Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population

NCT02518698 · clinicaltrials.gov ↗

COMPLETED

Status

1163

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Radium-223 dichloride (Xofigo, BAY88-8223)

Sponsor

Bayer